Free Trial
NASDAQ:CERO

CERo Therapeutics (CERO) Stock Price, News & Analysis

$0.97
-0.09 (-8.47%)
(As of 05/29/2024 ET)
Today's Range
$0.97
$1.08
50-Day Range
$0.92
$3.07
52-Week Range
$0.87
$12.80
Volume
55,394 shs
Average Volume
761,327 shs
Market Capitalization
$14.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CERO stock logo

About CERo Therapeutics Stock (NASDAQ:CERO)

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

CERO Stock Price History

CERO Stock News Headlines

See More Headlines
Receive CERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:CERO
Previous Symbol
NASDAQ:CERO
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
12,682,000
Market Cap
$14.87 million
Optionable
N/A
Beta
-0.08
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Daniel Mark Corey M.D. (Age 45)
    Founder, CTO & Director
    Comp: $372.69k
  • Mr. Brian G. Atwood (Age 71)
    President, CEO & Chairman
  • Mr. Charles Ross Carter (Age 56)
    CFO, Treasurer & Corporate Secretary
  • Dr. Robert Sikorski M.D. (Age 61)
    Ph.D., Consultant

CERO Stock Analysis - Frequently Asked Questions

How have CERO shares performed in 2024?

CERo Therapeutics' stock was trading at $4.78 at the beginning of the year. Since then, CERO shares have decreased by 79.7% and is now trading at $0.9726.
View the best growth stocks for 2024 here
.

How do I buy shares of CERo Therapeutics?

Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CERO) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners